ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China · Delayed Price · Currency is CNY

33.20

-1.17 (-3.40%)

Sep 24, 2026, 3:04 PM CST

Market Cap	14.89B -43.8%
Revenue (ttm)	840.19M -25.1%
Net Income	220.47M
EPS	0.49
Shares Out	448.53M
PE Ratio	68.02
Forward PE	28.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,514,326
Open	34.47
Previous Close	34.37
Day's Range	33.18 - 34.47
52-Week Range	29.31 - 62.50
Beta	0.77
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical C... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 1,294

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300723

Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements